Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Approaches for creating a COVID-19 vaccine

Posted on March 16th, 2020 by

Before the coronavirus disease 2019 (COVID-19) pandemic, no one had ever heard of the causative agent 2019 novel coronavirus (SARS-Cov-2). There were no approved antivirals or vaccines for this virus or for any related coronaviruses (e.g., severe acute respiratory syndrome–associated coronavirus (SARS-CoV) or Middle East respiratory syndrome coronavirus).

(more…)

3 issues global pharmas should consider as the coronavirus outbreak continues

Posted on February 26th, 2020 by

It has been more than four weeks since the Wuhan lockdown on January 23. As the crisis unfolded, spring festival national holidays were extended (and extended again), and finally people are now gradually going back to work—though some cities, towns and villages are still taking strict measures to prevent the virus spreading further.

(more…)

Life science community shares research to combat coronavirus

Posted on February 13th, 2020 by

After weeks of rising concern about the rapid spread of the coronavirus in China’s Wuhan province, on January 31 the World Health Organization (WHO) declared it a global health emergency. But the story of the coronavirus outbreak is about more than a health scare – it is a terribly sad human tragedy. Already (as of this writing) over 40,000 people have been infected and over 1,000 have died since the outbreak began in December, and it is children and the elderly who have suffered most.

(more…)

  1. 1
  2. …
  3. 4
  4. 5
  5. 6